OCUCURE

Serial Number 86182117
606

Registration Progress

Application Filed
Feb 2, 2014
Under Examination
Aug 12, 2014
Approved for Publication
Jun 17, 2014
Published for Opposition
Jun 17, 2014
Registered

Basic Information

Serial Number
86182117
Filing Date
February 2, 2014
Published for Opposition
June 17, 2014
Abandonment Date
September 18, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 18, 2017
Classes
005

Rights Holder

Ocucure Therapeutics, Inc.

03
Address
15 East Salem Avenue, Suite 201
Roanoke, VA 24011

Ownership History

Ocucure Therapeutics, Inc.

Original Applicant
03
Roanoke, VA

Ocucure Therapeutics, Inc.

Owner at Publication
03
Roanoke, VA

Legal Representation

Attorney
Carole R. Klein
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE Jul 17, 2014 4008 days overdue Medium Until Aug 17, 2014

Application History

34 events
Date Code Type Description
Sep 18, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Sep 18, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 22, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2017 EX5G S SOU EXTENSION 5 GRANTED
Feb 7, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 2, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 2, 2017 EXT5 S SOU EXTENSION 5 FILED
Aug 23, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2016 EX4G S SOU EXTENSION 4 GRANTED
Aug 8, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 8, 2016 EXT4 S SOU EXTENSION 4 FILED
Mar 19, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2016 EX3G S SOU EXTENSION 3 GRANTED
Mar 16, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 11, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 11, 2016 EXT3 S SOU EXTENSION 3 FILED
Aug 26, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2015 EX2G S SOU EXTENSION 2 GRANTED
Aug 23, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 5, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 5, 2015 EXT2 S SOU EXTENSION 2 FILED
Feb 14, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 12, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 12, 2015 EXT1 S SOU EXTENSION 1 FILED
Feb 12, 2015 EX1G S SOU EXTENSION 1 GRANTED
Aug 12, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 17, 2014 PUBO A PUBLISHED FOR OPPOSITION
Jun 17, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2014 DOCK D ASSIGNED TO EXAMINER
Feb 14, 2014 MPMK E NOTICE OF PSEUDO MARK E-MAILED
Feb 13, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Ocular Pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0

Active Deadlines

Notice of Publication
Due: Jul 17, 2014 Overdue

Additional Information

Pseudo Mark
OCULAR CURE

Classification

International Classes
005